Filtered By:
Specialty: Complementary Medicine
Condition: Multiple Sclerosis

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1 results found since Jan 2013.

Immunomodulatory drugs (natalizumab), worsening of multiple sclerosis, rebound effect and similitude.
CONCLUSION: Relapses of MS after discontinuation of natalizumab treatment indicate rebound of disease activity, supporting the homeopathic principle and warning healthcare professionals about this serious iatrogenic event. PMID: 23870382 [PubMed - in process]
Source: Homeopathy - July 1, 2013 Category: Complementary Medicine Authors: Teixeira MZ Tags: Homeopathy Source Type: research